Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Si-Bone (SIBN) EBITDA (2017 - 2025)

Si-Bone (SIBN) has 9 years of EBITDA data on record, last reported at -$1.6 million in Q4 2025.

  • For Q4 2025, EBITDA rose 66.89% year-over-year to -$1.6 million; the TTM value through Dec 2025 reached -$18.3 million, up 40.87%, while the annual FY2025 figure was -$18.3 million, 40.87% up from the prior year.
  • EBITDA reached -$1.6 million in Q4 2025 per SIBN's latest filing, up from -$4.5 million in the prior quarter.
  • Across five years, EBITDA topped out at -$1.6 million in Q4 2025 and bottomed at -$18.6 million in Q2 2022.
  • Average EBITDA over 5 years is -$10.5 million, with a median of -$11.0 million recorded in 2023.
  • Peak YoY movement for EBITDA: crashed 64.76% in 2021, then soared 66.89% in 2025.
  • A 5-year view of EBITDA shows it stood at -$14.6 million in 2021, then rose by 23.72% to -$11.1 million in 2022, then grew by 0.86% to -$11.0 million in 2023, then surged by 56.08% to -$4.8 million in 2024, then skyrocketed by 66.89% to -$1.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were -$1.6 million in Q4 2025, -$4.5 million in Q3 2025, and -$5.8 million in Q2 2025.